Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy
- PMID: 3128500
- PMCID: PMC5907764
- DOI: 10.1111/j.1349-7006.1988.tb00019.x
Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy
Abstract
The effects of PSK on OKT 4/OKT 8 cell ratio, interleukin-2 (IL-2) production and expression of IL-2 receptor were examined in peripheral blood lymphocytes (PBL) from patients with advanced ovarian cancer during the course of chemotherapy. Preoperative levels of OKT 4/OKT 8 cell ratio and IL-2 production in PBL from patients with advanced ovarian cancer were significantly lower than those in cases of benign ovarian tumor. However, the expression of IL-2 receptor did not show any significant difference between ovarian cancer and benign ovarian tumor patients. When a combination chemotherapy of cisplatin, adriamycin and cyclophosphamide was given, the OKT 4/OKT 8 cell ratio was significantly increased with a significant decrease of the absolute number of the OKT 8 cell subset, while the expression of IL-2 receptor and the absolute number of the OKT 4 cell subset remained unchanged. In contrast, the IL-2 production was markedly depressed after the first course of chemotherapy. When PSK was combined with combination chemotherapy, the degree of inhibition of IL-2 production was reduced (though the effect was not statistically significant). If treatment with PSK was initiated after completion of combination chemotherapy, in addition to a significant elevation of OKT 4/OKT 8 cell ratio the depressed IL-2 production was restored to benign control levels. On the other hand, the expression of IL-2 receptor remained unchanged even if PSK was given after completion of chemotherapy.
References
-
- Jurin , M. and Suit , H. D.In vitro activity of lymphocytes and serum of C3H5/Bu mice during the growth of methylcholanthrene‐induced tumor and its regression following local irradiation . Cancer Res. , 34 , 672 – 678 ( 1974. ). - PubMed
-
- Paranjpe , M. S. and Boone , C. W.Kinetics of the anti‐tumor delayed hypersensitivity response in mice with progressively growing tumors: stimulation followed by specific suppression . Int. J. Cancer , 13 , 179 – 186 ( 1974. ). - PubMed
-
- Sidkey , Y. A. and Auerbach , R.Lymphocyte‐induced angiogenesis in tumor‐bearing mice . Science , 192 , 1237 – 1238 ( 1976. ). - PubMed
-
- Mills , G. B. and Paetkau , V.Generation of cytotoxic lymphocytes to syngeneic tumor by using co‐stimulator (interleukin 2) . J. Immunol. , 125 , 1897 – 1903 ( 1980. ). - PubMed
-
- Burger , C. J. , Elgert , K. D. and Farrar , W. L.Interleukin 2 (IL‐2) activity during tumor growth: IL‐2 production kinetics, absorption of and responses to exogenous IL‐2 . Cell Immunol. , 84 , 228 – 239 ( 1984. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous